The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-benzyl-2,4-dihydroxy-5-methyl-N-(4-(methyl(quinoxalin-6-ylmethyl)carbamoyl)phenyl)benzamide ID: ALA3732285
PubChem CID: 117972700
Max Phase: Preclinical
Molecular Formula: C32H28N4O4
Molecular Weight: 532.60
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C(=O)N(Cc2ccccc2)c2ccc(C(=O)N(C)Cc3ccc4nccnc4c3)cc2)c(O)cc1O
Standard InChI: InChI=1S/C32H28N4O4/c1-21-16-26(30(38)18-29(21)37)32(40)36(20-22-6-4-3-5-7-22)25-11-9-24(10-12-25)31(39)35(2)19-23-8-13-27-28(17-23)34-15-14-33-27/h3-18,37-38H,19-20H2,1-2H3
Standard InChI Key: YZZSZNYNWZBIOJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 44 0 0 0 0 0 0 0 0999 V2000
-7.7820 -5.2538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0762 -6.0121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3800 -5.2704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3897 -3.7704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0954 -3.0122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7916 -3.7538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.7390 -5.8471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-11.4154 -5.8771 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-11.6927 -3.0257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.7291 -3.6305 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-11.7002 -1.5249 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-13.0032 -0.7802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.0107 0.7207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.4041 -0.7684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.4091 0.7316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.1125 1.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8109 0.7403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8060 -0.7598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.1025 -1.5141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.3120 1.4669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.3164 2.9669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.0196 3.7207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.7184 2.9746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.7139 1.4746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5121 1.4924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2109 0.7445 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.5141 2.6924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9122 1.4966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2090 -0.4555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.7562 -3.1472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
3 8 1 0
4 9 1 0
9 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
11 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
13 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 13 1 0
17 25 1 0
25 26 1 0
25 27 2 0
26 28 1 0
28 29 1 0
26 30 1 0
29 31 2 0
31 35 1 0
34 32 1 0
32 33 2 0
33 29 1 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 39 1 0
39 34 2 0
6 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 532.60Molecular Weight (Monoisotopic): 532.2111AlogP: 5.47#Rotatable Bonds: 7Polar Surface Area: 106.86Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.23CX Basic pKa: 1.70CX LogP: 4.91CX LogD: 4.85Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.29Np Likeness Score: -1.13
References 1. (2015) Resorcinol n-aryl amide compounds, for use as pyruvate dehydrogenase kinase inhibitors, 2. Morrell, J A JA and 5 more authors. 2003-12 AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2. [PMID:14641019 ] 3. Meng, Tao T and 10 more authors. 2014-12-11 Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90. [PMID:25383915 ] 4. Moore, Jonathan D and 12 more authors. 2014-12-30 VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells. [PMID:25404640 ] 5. Narayan, Satya S and 7 more authors. 2019-01-01 ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. [PMID:30384048 ]